Market Research Logo

Global Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2026

Global Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2026

Short Description

By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Market Definition:
Drug safety and pharmacovigilance can be well-defined as the science and activities associated with the detection, assessment, understanding and preclusion of antagonistic drug action or any other adverse drug reactions. Pharmacovigilance (PV) as defined by the European Commission (EU) is the “process and science of observing the safety of drugs and taking action to minimize the adverse drug reactions and increase the benefits of medicines”.
Drug Safety and Pharmacovigilance can be beneficial in the various assessments such as medication errors, adverse interactions of medicines with chemicals, other medicines, and food, public health and safety in relation to the use of medicines, case reports of acute and chronic poisoning, abuse and misuse of medicines and others.
Market Segmentation:
Global drug safety solutions and pharmacovigilance market is segmented into three notable segments which are type, end user and distribution channel.
 On the basis of type, the market is segmented into software and services
 On the basis of end user, the market is segmented into hospitals, healthcare providers, pharmaceutical & biotechnology industries, KPOs/BPOs, contract research organizations (CROS) and others
 On the basis of distribution channel, the market is segmented into direct sales and retail sales
Market Players
The key market players for global drug safety solutions and pharmacovigilance market are listed below:
• Pharmaceutical Product Development, LLC
• Drug Safety Solutions Limited
• C3i
• Worldwide Clinical Trials
• Bioclinica
• United Biosource LLC
• Ennov
• AB Cube
• Covance Inc.
• Accenture
• PRA Health Sciences, Inc.
• Ergomed
• IQVIA
• Genpact
• Cognizant
• Parexel International Corporation
• ArisGlobal
• ICON plc
• Oracle
• Syneos Health

The single user license is non-downloadable and non-printable. Global Site license allows these actions.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Drug Safety Solutions & Pharmacovigilance Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Secondary Sources
2.11 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Increasing Number Of Clinical Trials
3.1.2 Growing Number Of Contract Research Organizations
3.1.3 Increase In R & D Expenditure By Pharmaceutical And Biopharmaceutical Companies
3.1.4 Increase In The Number Of Adverse Drug Reactions (Adrs)
3.2 Restraint
3.2.1 High Cost Of Drug Safety Solutions & Pharmacovigilance
3.3 Opportunities
3.3.1 Automation In Drug Safety Solutions & Pharmacovigilance
3.3.2 Research Collaborations And Partnerships
3.3.3 Strategic Initiatives By Market Players
3.4 Challenge
3.4.1 The Misreporting And Miscoding Of Adverse Events
4 Executive Summary
5 Global Drug Safety Solutions & Pharmacovigilance Market, By Type
5.1 Overview
5.2 Software
5.2.1 Adverse Event Reporting Software
5.2.1.1 On-premise
5.2.1.2 Cloud Based
5.2.2 Drug Safety Audits Software
5.2.2.1 On-premise
5.2.2.2 Cloud Based
5.2.3 Data Management Software
5.2.3.1 On-premise
5.2.3.2 Cloud Based
5.2.4 Fully Integrated Software
5.2.4.1 On-premise
5.2.4.2 Cloud Based
5.2.5 Issue Tracking Software
5.2.5.1 On-premise
5.2.5.2 Cloud Based
5.2.6 Clinical Trial Management Solution
5.2.6.1 On-premise
5.2.6.2 Cloud Based
5.2.7 Regulatory Content And Information Management Software
5.2.7.1 On-premise
5.2.7.2 Cloud Based
5.2.8 Medical Affairs Software
5.2.8.1 On-premise
5.2.8.2 Cloud Based
5.2.9 Others
5.2.9.1 On-premise
5.2.9.2 Cloud Based
5.3 Services
5.3.1 Clinical Data Management
5.3.1.1 Data Entry And Case Processing
5.3.1.2 Clinical Trial Monitoring
5.3.1.3 Clinical Trial Safety Submissions
5.3.1.4 Case Processing (Saes)
5.3.1.5 Others
5.3.2 Drug Safety Solutions
5.3.2.1 Quality And Medical Review
5.3.2.2 Literature And Social Media Monitoring
5.3.2.3 Safety Database
5.3.2.4 Individual Case Study Report
5.3.2.5 Periodic Reports
5.3.2.6 Medical Literature Search
5.3.2.7 Signal Detection
5.3.2.8 Expedited Reports
5.3.2.9 Others
5.3.3 Aggregate Safety Reporting
5.3.4 Regulatory Services
5.3.4.1 Safety Regulatory Submissions
5.3.4.2 Post-marketing Surveillance
5.3.4.3 Medical Device Vigilance
5.3.4.4 Regulatory Consulting
5.3.4.5 Others
5.3.5 Risk Management Services
5.3.6 Medical Information Call Center Services
5.3.7 Audit Services
5.3.8 Training Support Services
5.3.9 Others
6 Global Drug Safety Solutions & Pharmacovigilance Market,
By End Users
6.1 Overview
6.2 Pharmaceutical & Biotechnology Industries
6.3 Contract Research Organizations (Cros)
6.4 Hospitals
6.5 Kpos/Bpos
6.6 Healthcare Providers
6.7 Others
7 Global Drug Safety Solutions & Pharmacovigilance Market,
By Distribution Channel
7.1 Overview
7.2 Direct Sales
7.3 Retail Sales
8 Drug Safety Solutions & Pharmacovigilance Market, By Geography
9 Global Drug Safety Solutions & Pharmacovigilance Market,
By Geography
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 United Kingdom
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Russia
9.3.7 Netherlands
9.3.8 Switzerland
9.3.9 Belgium
9.3.10 Turkey
9.3.11 Austria
9.3.12 Ireland
9.3.13 Norway
9.3.14 Hungary
9.3.15 Poland
9.3.16 Lithuania
9.3.17 Rest Of Europe
9.4 Asia-pacific
9.4.1 China
9.4.2 Japan
9.4.3 South Korea
9.4.4 India
9.4.5 Australia
9.4.6 Singapore
9.4.7 Thailand
9.4.8 Malaysia
9.4.9 Indonesia
9.4.10 Philippines
9.4.11 Vietnam
9.4.12 Rest Of Asia-pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Peru
9.5.4 Rest Of South America
9.6 Middle East And Africa
9.6.1 Uae
9.6.2 Saudi Arabia
9.6.3 Kuwait
9.6.4 South Africa
9.6.5 Rest Of Middle East And Africa
10 Global Drug Safety Solutions & Pharmacovigilance Market, Company Landscape
10.1 Company Share Analysis: Global
10.2 Company Share Analysis: North America
10.3 Company Share Analysis: Europe
10.4 Company Share Analysis: Asia-pacific
11 Company Profile
11.1 Syneos Health
11.1.1 Company Snapshot
11.1.2 Revenue Analysis
11.1.3 Company Share Analysis
11.1.4 Solution Portfolio
11.1.5 Recent Development
11.2 Covance Inc. (A Subsidiary Of Labcorp)
11.2.1 Company Snapshot
11.2.2 Revenue Analysis
11.2.3 Company Share Analysis
11.2.4 Service Portfolio
11.2.5 Recent Developments
11.3 Cognizant
11.3.1 Company Snapshot
11.3.2 Revenue Analysis
11.3.3 Company Share Analysis
11.3.4 Solution Portfolio
11.3.5 Recent Development
11.4 Accenture
11.4.1 Company Snapshot
11.4.2 Revenue Analysis
11.4.3 Company Share Analysis
11.4.4 Service Portfolio
11.4.5 Recent Developments
11.5 Parexel International Corporation
11.5.1 Company Snapshot
11.5.2 Product Portfolio
11.5.3 Recent Developments
11.6 Oracle
11.6.1 Company Snapshot
11.6.2 Revenue Analysis
11.6.3 Solution Portfolio
11.6.4 Recent Development
11.7 Ab Cube
11.7.1 Company Snapshot
11.7.2 Solution Portfolio
11.7.3 Recent Development
11.8 Arisglobal
11.8.1 Company Snapshot
11.8.2 Product Portfolio
11.8.3 Recent Developments
11.9 Bioclinica
11.9.1 Company Snapshot
11.9.2 Service Portfolio
11.9.3 Recent Developments
11.10 C3i
11.10.1 Company Snapshot
11.10.2 Revenue Analysis
11.10.3 Service Portfolio
11.10.4 Recent Developments
11.11 Drug Safety Solutions Limited
11.11.1 Company Snapshot
11.11.2 Service Portfolio
11.11.3 Recent Development
11.12 Ennov
11.12.1 Company Snapshot
11.12.2 Product Portfolio
11.12.3 Recent Developments
11.13 Ergomed Plc
11.13.1 Company Snapshot
11.13.2 Revenue Analysis
11.13.3 Service Portfolio
11.13.4 Recent Developments
11.14 Genpact
11.14.1 Company Snapshot
11.14.2 Revenue Analysis
11.14.3 Product Portfolio
11.14.4 Recent Developments
11.15 Icon Plc
11.15.1 Company Snapshot
11.15.2 Revenue Analysis
11.15.3 Service Portfolio
11.15.4 Recent Developments
11.16 Iqvia
11.16.1 Company Snapshot
11.16.2 Revenue Analysis
11.16.3 Solution Portfolio
11.16.4 Recent Developments
11.17 Pharmaceutical Product Development, Llc.
11.17.1 Company Snapshot
11.17.2 Service Portfolio
11.17.3 Recent Developments
11.18 Pharmaceutical Research Associates Inc.
11.18.1 Company Snapshot
11.18.2 Revenue Analysis
11.18.3 Solution Portfolio
11.18.4 Recent Developments
11.19 United Biosource Llc
11.19.1 Company Snapshot
11.19.2 Service Portfolio
11.19.3 Recent Development
11.20 Worldwide Clinical Trials
11.20.1 Company Snapshot
11.20.2 Service Portfolio
11.20.3 Recent Developments
12 Questionnaire
13 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook